US Broker Ratings

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Strong Buy Ratings and a Promising 48% Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a prominent player in the biotechnology sector, has captured investor attention with its innovative therapies aimed at treating life-threatening rare diseases. With a market capitalization..

Novo Nordisk A/S (NVO) Stock Analysis: Evaluating Its 9.64% Potential Upside for Investors

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture the interest of investors worldwide. With a market capitalization of $220.42 billion, the Denmark-based pharmaceutical giant..

Insulet Corporation (PODD) Stock Analysis: A 52.28% Upside Potential Beckons Investors

For investors seeking opportunities in the healthcare sector, Insulet Corporation (NASDAQ: PODD), with its focus on innovative insulin delivery systems, presents a compelling prospect. With a market cap of $17.09..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Powerhouse with 6.93% Upside Potential

Vertex Pharmaceuticals Incorporated (VRTX), a key player in the biotechnology sector, continues to capture the attention of investors with its robust pipeline and strong market presence. With a market capitalization..

Cardinal Health (CAH) Stock Analysis: A Healthcare Giant with 12.23% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) is a prominent player in the healthcare sector, particularly known for its robust operations in medical distribution. With a market capitalization of $51.96 billion, this..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 20% Upside Potential in the Animal Health Sector

Zoetis Inc. (ZTS), a leader in the animal health sector, is capturing investor attention with its robust market presence and a compelling potential upside of 20.07%. With a market capitalization..

Biogen Inc. (BIIB) Stock Analysis: Navigating a 4.58% Upside Potential Amidst Healthcare Innovations

As a prominent player in the healthcare sector, Biogen Inc. (NASDAQ: BIIB) stands at the forefront of innovative drug development, specializing in therapies for neurologic and immunologic diseases. With a..

UnitedHealth Group (UNH) Stock Analysis: Examining a 24.36% Potential Upside Amidst Robust Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, stands out as a compelling investment opportunity with a notable potential upside of 24.36%. This analysis delves into the..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the Performance and Growth Potential of a Biotech Giant

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to assert its dominance in the drug manufacturing industry. With a sprawling market capitalization of nearly $199 billion, Amgen..

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with Robust Analyst Buy Ratings and a Healthy Dividend Yield

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, stands out in the drug manufacturers industry with a significant market capitalization of $409.15 billion. Since its inception in..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Analyzing the 46% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, is capturing investor attention with a significant potential upside of 46.12%. With a market capitalization of $41.7 billion, this..

Tenet Healthcare (THC) Stock Analysis: Navigating a 10.32% Potential Upside in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player within the U.S. healthcare industry, boasting a market capitalization of $20.42 billion. As an entity operating in the medical care..

ResMed Inc. (RMD) Stock Analysis: Evaluating a 17.79% Potential Upside for Investors

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, specializes in developing innovative medical devices and cloud-based software applications to manage respiratory disorders. With a market capitalization of..

IDEXX Laboratories, Inc. (IDXX) Investor Outlook: Exploring a 19.21% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within diagnostics and research, is currently capturing the attention of investors with its promising potential for growth...

argenx SE (ARGX) Stock Analysis: Biotechnology Giant with 25.90% Upside Potential

Investors with an eye on the biotechnology sector might find argenx SE (NASDAQ: ARGX) a compelling opportunity, particularly given its significant market cap of $50.87 billion. Operating primarily in the..

Sanofi (SNY) Stock Analysis: A 25% Potential Upside with Strong Dividend Yield

Sanofi (SNY), a global healthcare leader headquartered in Paris, France, is making waves in the pharmaceutical industry with its robust portfolio of therapeutic solutions and vaccines. With a market capitalization..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Uncovering a 10% Upside Potential for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a prominent player in the global healthcare sector, continues to capture the attention of investors seeking growth in the drug manufacturing industry. With a..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.24% Dividend Yield Amidst Market Complexity

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to captivate investors with its robust portfolio of biopharmaceutical products and a compelling dividend yield of 6.24%. This New..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a 9.1% Revenue Growth in Healthcare

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, is navigating a complex landscape with a market cap standing tall at $586.69 billion. As the company continues to..

STERIS plc (STE) Stock Analysis: Attractive Growth Potential with 13.25% Upside

STERIS plc (NYSE: STE) is a prominent player in the medical devices industry, renowned for its infection prevention products and services. Operating globally, STERIS is structured into three segments: Healthcare,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds